ZA991102B - Gene transfer-mediated angiogenesis therapy and techniques for intravascular gene delivery. - Google Patents
Gene transfer-mediated angiogenesis therapy and techniques for intravascular gene delivery.Info
- Publication number
- ZA991102B ZA991102B ZA9901102A ZA991102A ZA991102B ZA 991102 B ZA991102 B ZA 991102B ZA 9901102 A ZA9901102 A ZA 9901102A ZA 991102 A ZA991102 A ZA 991102A ZA 991102 B ZA991102 B ZA 991102B
- Authority
- ZA
- South Africa
- Prior art keywords
- techniques
- intravascular
- gene
- mediated angiogenesis
- angiogenesis therapy
- Prior art date
Links
- 230000033115 angiogenesis Effects 0.000 title 1
- 238000001476 gene delivery Methods 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Paints Or Removers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2177398A | 1998-02-11 | 1998-02-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA991102B true ZA991102B (en) | 2000-03-31 |
Family
ID=21806073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9901102A ZA991102B (en) | 1998-02-11 | 1999-02-11 | Gene transfer-mediated angiogenesis therapy and techniques for intravascular gene delivery. |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP1053025A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002502885A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20010015915A (cg-RX-API-DMAC7.html) |
| CN (2) | CN100350979C (cg-RX-API-DMAC7.html) |
| AU (1) | AU2663799A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2320302A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA019099B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL137765A0 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ545047A (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999040945A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA991102B (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6752987B1 (en) | 1995-02-28 | 2004-06-22 | The Regents Of The University Of California | Adenovirus encoding human adenylylcyclase (AC) VI |
| US20020103147A1 (en) | 1997-09-05 | 2002-08-01 | Hammond H. Kirk | Gene therapy for congestive heart failure |
| WO2000024415A2 (en) | 1998-10-28 | 2000-05-04 | Cornell Research Foundation, Inc. | Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
| HK1048593A1 (zh) * | 1999-11-05 | 2003-04-11 | The Regents Of The University Of California | 用於通过体内基因输送治疗心血管疾病的技术和组合物 |
| CA2412847A1 (en) * | 2000-06-30 | 2002-01-10 | Collateral Therapeutics, Inc. | Dual recombinant gene therapy compositions and methods of use |
| JP2005052001A (ja) * | 2001-07-05 | 2005-03-03 | Takara Bio Inc | 遺伝子治療剤 |
| EP2236153A3 (en) | 2005-01-25 | 2012-08-22 | Five Prime Therapeutics, Inc. | Compositons and methods for treating cardiac conditions |
| PL2044199T3 (pl) * | 2006-07-25 | 2013-04-30 | Celladon Corp | Przedłużony, podawany z prądem krwi, nasierdziowy, wieńcowy wlew wektorów wirusowych na bazie wirusów towarzyszących adenowirusom, zawierający SERCA2a do terapii genowej |
| JP5290290B2 (ja) | 2007-07-18 | 2013-09-18 | シルク・ロード・メディカル・インコーポレイテッド | 頚動脈血流の逆流を確立する方法およびシステム |
| EP2244740A1 (en) | 2008-02-19 | 2010-11-03 | Celladon Corporation | Compositions for enhanced uptake of viral vectors in the myocardium |
| US20130096500A1 (en) * | 2011-07-07 | 2013-04-18 | Gabor Rubanyi | Nucleic acid based cardiovascular therapeutics |
| WO2014160887A2 (en) * | 2013-03-28 | 2014-10-02 | Silk Road Medical, Inc. | Methods and systems for establishing retrograde carotid arterial blood flow |
| WO2019089385A1 (en) | 2017-11-02 | 2019-05-09 | Silk Road Medical, Inc. | Fenestrated sheath for embolic protection during transcarotid carotid artery revascularization |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6100242A (en) * | 1995-02-28 | 2000-08-08 | The Regents Of The University Of California | Gene therapies for enhancing cardiac function |
| US5869230A (en) * | 1995-03-30 | 1999-02-09 | Beth Israel Hospital Association | Gene transfer into the kidney |
| WO1999017807A1 (en) * | 1997-10-08 | 1999-04-15 | Cobra Therapeutics Ltd. | Use of a vasoactive compound in the enhancement of gene delivery |
| WO1999018792A1 (en) * | 1997-10-10 | 1999-04-22 | Johns Hopkins University | Gene delivery compositions and methods |
-
1999
- 1999-02-09 EP EP99906814A patent/EP1053025A2/en not_active Withdrawn
- 1999-02-09 JP JP2000531196A patent/JP2002502885A/ja active Pending
- 1999-02-09 AU AU26637/99A patent/AU2663799A/en not_active Abandoned
- 1999-02-09 CA CA002320302A patent/CA2320302A1/en not_active Abandoned
- 1999-02-09 WO PCT/US1999/002702 patent/WO1999040945A2/en not_active Ceased
- 1999-02-09 EP EP05026675A patent/EP1695719A1/en not_active Withdrawn
- 1999-02-09 EA EA200000828A patent/EA019099B1/ru not_active IP Right Cessation
- 1999-02-09 CN CNB998049425A patent/CN100350979C/zh not_active Expired - Fee Related
- 1999-02-09 IL IL13776599A patent/IL137765A0/xx unknown
- 1999-02-09 CN CNA2007101808364A patent/CN101186928A/zh active Pending
- 1999-02-09 KR KR1020007008781A patent/KR20010015915A/ko not_active Ceased
- 1999-02-09 NZ NZ545047A patent/NZ545047A/en not_active IP Right Cessation
- 1999-02-11 ZA ZA9901102A patent/ZA991102B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2320302A1 (en) | 1999-08-19 |
| WO1999040945A2 (en) | 1999-08-19 |
| IL137765A0 (en) | 2001-10-31 |
| WO1999040945A3 (en) | 1999-09-30 |
| EP1695719A1 (en) | 2006-08-30 |
| CN101186928A (zh) | 2008-05-28 |
| CN1301181A (zh) | 2001-06-27 |
| CN100350979C (zh) | 2007-11-28 |
| JP2002502885A (ja) | 2002-01-29 |
| EA200000828A1 (ru) | 2001-02-26 |
| AU2663799A (en) | 1999-08-30 |
| EA019099B1 (ru) | 2014-01-30 |
| KR20010015915A (ko) | 2001-02-26 |
| EP1053025A2 (en) | 2000-11-22 |
| NZ545047A (en) | 2009-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3342599A (en) | Delivery catheter | |
| EP0915721A4 (en) | INTRAVASCULAR ADMINISTRATION BY ELECTROPORATION | |
| ZA987839B (en) | Combination therapy. | |
| ZA99877B (en) | Inhalant medicator. | |
| AU9595598A (en) | Peripheral vascular delivery catheter | |
| ZA971324B (en) | Powdered medication inhaler. | |
| ZA987844B (en) | Therapeutic combinations. | |
| ZA989061B (en) | Medicaments. | |
| EP1011787A4 (en) | INTRAVASCULAR RADIATION DELIVERY SYSTEM | |
| ZA987843B (en) | Combination therapy. | |
| ZA975065B (en) | Delivery needle. | |
| IL117309A0 (en) | Gene transfer-mediated angiogenesis therapy | |
| EP0938352A4 (en) | DRAINAGE CATHETER INSTALLATION SYSTEM | |
| MXPA02001088A (es) | 2-pirazolin-5-onas.. | |
| ZA97976B (en) | Uniform drug delivery theraphy. | |
| ZA99283B (en) | Inhaler for medication. | |
| ZA971272B (en) | Gene expression. | |
| ZA99880B (en) | Inhalant medicator. | |
| GB2359267B (en) | Aroma therapy delivery system | |
| IL121516A0 (en) | Catheter | |
| GB9811691D0 (en) | Flavour delivery systems | |
| ZA200007111B (en) | Methods and devices for providing prolonged drug therapy. | |
| ZA200110046B (en) | Therapeutic agents. | |
| GB9924981D0 (en) | Gene therapy | |
| ZA991786B (en) | Therapeutic treatment for asthma. |